177 related articles for article (PubMed ID: 38212656)
1. A protective role of ABCA5 in response to elevated sphingomyelin levels in Parkinson's disease.
Fu Y; Pickford R; Galper J; Phan K; Wu P; Li H; Kim YB; Dzamko N; Halliday GM; Kim WS
NPJ Parkinsons Dis; 2024 Jan; 10(1):20. PubMed ID: 38212656
[TBL] [Abstract][Full Text] [Related]
2. Changes in sphingomyelin level affect alpha-synuclein and ABCA5 expression.
Kim WS; Halliday GM
J Parkinsons Dis; 2012; 2(1):41-6. PubMed ID: 23939407
[TBL] [Abstract][Full Text] [Related]
3. Sphingolipid changes in Parkinson L444P GBA mutation fibroblasts promote α-synuclein aggregation.
Galvagnion C; Marlet FR; Cerri S; Schapira AHV; Blandini F; Di Monte DA
Brain; 2022 Apr; 145(3):1038-1051. PubMed ID: 35362022
[TBL] [Abstract][Full Text] [Related]
4. ABCA5 regulates amyloid-β peptide production and is associated with Alzheimer's disease neuropathology.
Fu Y; Hsiao JH; Paxinos G; Halliday GM; Kim WS
J Alzheimers Dis; 2015; 43(3):857-69. PubMed ID: 25125465
[TBL] [Abstract][Full Text] [Related]
5. ABCA5 resides in lysosomes, and ABCA5 knockout mice develop lysosomal disease-like symptoms.
Kubo Y; Sekiya S; Ohigashi M; Takenaka C; Tamura K; Nada S; Nishi T; Yamamoto A; Yamaguchi A
Mol Cell Biol; 2005 May; 25(10):4138-49. PubMed ID: 15870284
[TBL] [Abstract][Full Text] [Related]
6. Toll-like receptor 2 is increased in neurons in Parkinson's disease brain and may contribute to alpha-synuclein pathology.
Dzamko N; Gysbers A; Perera G; Bahar A; Shankar A; Gao J; Fu Y; Halliday GM
Acta Neuropathol; 2017 Feb; 133(2):303-319. PubMed ID: 27888296
[TBL] [Abstract][Full Text] [Related]
7. Lysosomal response in relation to α-synuclein pathology differs between Parkinson's disease and multiple system atrophy.
Puska G; Lutz MI; Molnar K; Regelsberger G; Ricken G; Pirker W; Laszlo L; Kovacs GG
Neurobiol Dis; 2018 Jun; 114():140-152. PubMed ID: 29505813
[TBL] [Abstract][Full Text] [Related]
8. Parkinson's disease: acid-glucocerebrosidase activity and alpha-synuclein clearance.
Blanz J; Saftig P
J Neurochem; 2016 Oct; 139 Suppl 1():198-215. PubMed ID: 26860955
[TBL] [Abstract][Full Text] [Related]
9. Reduced glucocerebrosidase is associated with increased α-synuclein in sporadic Parkinson's disease.
Murphy KE; Gysbers AM; Abbott SK; Tayebi N; Kim WS; Sidransky E; Cooper A; Garner B; Halliday GM
Brain; 2014 Mar; 137(Pt 3):834-48. PubMed ID: 24477431
[TBL] [Abstract][Full Text] [Related]
10. Impaired Sphingolipid Hydrolase Activities in Dementia with Lewy Bodies and Multiple System Atrophy.
Usenko TS; Senkevich KA; Bezrukova AI; Baydakova GV; Basharova KS; Zhuravlev AS; Gracheva EV; Kudrevatykh AV; Miliukhina IV; Krasakov IV; Khublarova LA; Fursova IV; Zakharov DV; Timofeeva AA; Irishina YA; Palchikova EI; Zalutskaya NM; Emelyanov AK; Zakharova EY; Pchelina SN
Mol Neurobiol; 2022 Apr; 59(4):2277-2287. PubMed ID: 35066761
[TBL] [Abstract][Full Text] [Related]
11. Reduced sphingolipid hydrolase activities, substrate accumulation and ganglioside decline in Parkinson's disease.
Huebecker M; Moloney EB; van der Spoel AC; Priestman DA; Isacson O; Hallett PJ; Platt FM
Mol Neurodegener; 2019 Nov; 14(1):40. PubMed ID: 31703585
[TBL] [Abstract][Full Text] [Related]
12. Lysosomal-associated membrane protein 2 isoforms are differentially affected in early Parkinson's disease.
Murphy KE; Gysbers AM; Abbott SK; Spiro AS; Furuta A; Cooper A; Garner B; Kabuta T; Halliday GM
Mov Disord; 2015 Oct; 30(12):1639-47. PubMed ID: 25594542
[TBL] [Abstract][Full Text] [Related]
13. Glucosylsphingosine Promotes α-Synuclein Pathology in Mutant GBA-Associated Parkinson's Disease.
Taguchi YV; Liu J; Ruan J; Pacheco J; Zhang X; Abbasi J; Keutzer J; Mistry PK; Chandra SS
J Neurosci; 2017 Oct; 37(40):9617-9631. PubMed ID: 28847804
[TBL] [Abstract][Full Text] [Related]
14. Activation of β-Glucocerebrosidase Reduces Pathological α-Synuclein and Restores Lysosomal Function in Parkinson's Patient Midbrain Neurons.
Mazzulli JR; Zunke F; Tsunemi T; Toker NJ; Jeon S; Burbulla LF; Patnaik S; Sidransky E; Marugan JJ; Sue CM; Krainc D
J Neurosci; 2016 Jul; 36(29):7693-706. PubMed ID: 27445146
[TBL] [Abstract][Full Text] [Related]
15. [Tandem mass tag-based quantitative proteomics analysis of plasma and plasma exosomes in Parkinson's disease].
Zhao Y; Liu X; Zhang Y; Zhang J; Liu X; Yang G
Se Pu; 2023 Dec; 41(12):1073-1083. PubMed ID: 38093537
[TBL] [Abstract][Full Text] [Related]
16. Glucosylceramide in cerebrospinal fluid of patients with GBA-associated and idiopathic Parkinson's disease enrolled in PPMI.
Huh YE; Park H; Chiang MSR; Tuncali I; Liu G; Locascio JJ; Shirvan J; Hutten SJ; Rotunno MS; Viel C; Shihabuddin LS; Wang B; Sardi SP; Scherzer CR
NPJ Parkinsons Dis; 2021 Nov; 7(1):102. PubMed ID: 34811369
[TBL] [Abstract][Full Text] [Related]
17. Correlation of induction of ATP binding cassette transporter A5 (ABCA5) and ABCB1 mRNAs with differentiation state of human colon tumor.
Ohtsuki S; Kamoi M; Watanabe Y; Suzuki H; Hori S; Terasaki T
Biol Pharm Bull; 2007 Jun; 30(6):1144-6. PubMed ID: 17541169
[TBL] [Abstract][Full Text] [Related]
18. Monoamine Oxidase-B Inhibition Facilitates α-Synuclein Secretion
Nakamura Y; Arawaka S; Sato H; Sasaki A; Shigekiyo T; Takahata K; Tsunekawa H; Kato T
J Neurosci; 2021 Sep; 41(35):7479-7491. PubMed ID: 34290084
[TBL] [Abstract][Full Text] [Related]
19. Lysosomal Dysfunction and α-Synuclein Aggregation in Parkinson's Disease: Diagnostic Links.
Moors T; Paciotti S; Chiasserini D; Calabresi P; Parnetti L; Beccari T; van de Berg WD
Mov Disord; 2016 Jun; 31(6):791-801. PubMed ID: 26923732
[TBL] [Abstract][Full Text] [Related]
20. The Emerging Role of the Lysosome in Parkinson's Disease.
Navarro-Romero A; Montpeyó M; Martinez-Vicente M
Cells; 2020 Nov; 9(11):. PubMed ID: 33147750
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
